Preoperative Identification of the Sentinel Lymph Node in Breast Cancer, Using Ultrasound and Radio-isotope/Percutaneous Gamma Probe
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Preoperative Identification of the Sentinel Lymph Node in Breast Cancer, Using Ultrasound and Radio-isotope/Percutaneous Gamma Probe
Inclusion Criteria:
- Diagnosed with invasive breast cancer suitable for primary surgical treatment
- Booked for surgical Sentinel Lymph Node Biopsy
Exclusion Criteria:
- Unable to give informed consent
- Known bleeding disorder
- Previous axillary surgery
- Previously treated for the current tumour with chemotherapy or hormone therapy
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Is the sentinel lymph node marked preoperatively confirmed as the SLN at surgery?
Outcome Time Frame:
8 Months from start of trial.
Safety Issue:
No
Authority:
United Kingdom: Research Ethics Committee
Study ID:
2010ON03
NCT ID:
NCT01154972
Start Date:
April 2010
Completion Date:
November 2010
Related Keywords:
- Breast Cancer
- breast
- cancer
- sentinel lymph node
- Breast Neoplasms
Name | Location |
|---|
